Sorting the green from the chaff
The medical cannabis market remains a high-growth opportunity and there are now several ASX-listed stocks to choose from. As with all emerging sector opportunities, there will be a few winners and many losers. We review the sector to sort the good stocks from the chaff.
Global market opportunity
The global medical cannabis market is forecast to grow by 33% per annum over the next few years (see chart below). 50 countries have now taken steps to legalize medical cannabis, as have 34 of the 50 states in the US.